Results 171 to 180 of about 3,112,326 (355)
Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies
ABSTRACT Objective Sarcoglycanopathies are among the most severe limb‐girdle muscular dystrophies (LGMD), though milder presentations have been described. These diseases are primarily caused by missense variants, but the limited predictability of their effect on protein maturation, complex formation, and transport has hindered reliable genotype ...
Leonela Luce +72 more
wiley +1 more source
Yajun Qiao,1– 4,* Xingfang Zhang,2,5,6,* Hanxi Chen,2,5 Xinxin Liang,1– 4 Juan Guo,1,3 Qiannan Wang,2,5 Yi Ding,6 Lixin Wei,2,5 Hongtao Bi,2,4,5 Tingting Gao1,3 1School of Psychology, Chengdu Medical College, Chengdu, Sichuan, People’s ...
Qiao Y +9 more
doaj
The Role of TRPV1 Channel in Cosmetic Safety Evaluation. [PDF]
Zhang C, Zhou Y, Wang X, Wang F.
europepmc +1 more source
Thin-walled abscesses and lumen-apposing metal stent drainage: a critical evaluation of safety and efficacy [PDF]
Jinyu Wu, Wen Wang
openalex +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Efficacy and safety evaluation of HyperSperm treatment in human semen samples. [PDF]
Martinez-Vallejo MJ +9 more
europepmc +1 more source
ABSTRACT Objective Stereoelectroencephalography‐guided radiofrequency thermocoagulation (SEEG‐RFTC) has emerged as a safe and effective minimally invasive treatment for children with drug‐resistant focal epilepsy. Although evidence from real‐world studies remains limited, numerous pediatric cases have demonstrated promising outcomes. This retrospective
Weitao Chen +7 more
wiley +1 more source
Safety evaluation of jagua (genipin-glycine) blue as a food additive. [PDF]
EFSA Panel on Food Additives and Flavourings (FAF) +29 more
europepmc +1 more source

